Invention Grant
- Patent Title: Therapeutic agents with improved fibrinogen binding
-
Application No.: US13983031Application Date: 2012-02-01
-
Publication No.: US09724379B2Publication Date: 2017-08-08
- Inventor: Greg Walker
- Applicant: Greg Walker
- Applicant Address: GB Nottinghamshire
- Assignee: Haemostatix Limited
- Current Assignee: Haemostatix Limited
- Current Assignee Address: GB Nottinghamshire
- Agency: Seed IP Law Group LLP
- Priority: GB1101740.7 20110201
- International Application: PCT/GB2012/050217 WO 20120201
- International Announcement: WO2012/104638 WO 20120809
- Main IPC: A61K38/08
- IPC: A61K38/08 ; C07K17/00 ; C07K7/06 ; A61K47/48
Abstract:
Therapeutic agents with improved fibrinogen binding properties are described. The agents are suitable for use as artificial platelets, or for formation of biogels. Methods and intermediates for producing the agents, cross-linking agents for use in the methods, and biogels formed from, or comprising the agents, are also described.
Public/Granted literature
- US20140031293A1 THERAPEUTIC AGENTS WITH IMPROVED FIBRINOGEN BINDING Public/Granted day:2014-01-30
Information query
IPC分类:
